Trial intelligence / Profile preview

Go-Thermal: Thermography in Psoriatic Arthritis

NCT02841176Terminated

Sponsor
Imperial College Healthcare NHS Trust
Start
Jul 2016
Primary completion
Sep 2017
Modality
Monoclonal Antibodies
Countries
1
01

Overview

Open-label, single-arm trial of golimumab in psoriatic arthritis (PsA), sponsored by Imperial College Healthcare NHS Trust. Primary endpoint: Temperature over arthritic joint surface at 97 days. Started Jul 2016; status: terminated.

02

Drugs

golimumab
03

Conditions

psoriatic arthritis (PsA)

Beyond the preview

Go deeper on NCT02841176.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT02841176.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call